Mitochondrial-targeted liposome-based drug delivery – therapeutic potential and challenges

Abstract

Liposomes, as nanocarriers for therapeutics, are a prominent focus in translational medicine. Given their biocompatibility, liposomes are suitable drug delivery systems rendering highly efficient therapeutic outcomes with minimal off-site toxicity. In different scenarios of human disease, it is essential not only to maintain therapeutic drug levels but also to target them to the appropriate intracellular compartment. Mitochondria regulate cellular signalling, calcium balance, and energy production, playing a crucial role in various human diseases. The notion of focusing on mitochondria for targeted drug delivery was proposed several decades ago, yet the practical application of this idea and its translation to clinical use is still in development. Mitochondrial-targeted liposomes offer an alternative to standard drug delivery systems, potentially reducing off-target interactions, side effects, and drug dosage or frequency. To advance this field, it is imperative to integrate various disciplines such as efficient chemical design, pharmacology, pharmaceutics, and cell biology. This review summarises scientific advances in the design, development and characterisation of novel liposome-based drug delivery systems targeting the mitochondria while revisiting their translational potential.

Publication DOI: https://doi.org/10.1080/1061186X.2024.2437440
Divisions: College of Health & Life Sciences > Aston Medical School > Translational Medicine Research Group (TMRG)
College of Health & Life Sciences
College of Health & Life Sciences > Aston Medical School
Aston University (General)
Funding Information: This research was funded the Royal Society Grant-Round 1 2021 (RGS/R1/221169) awarded to LSA.
Additional Information: Copyright © 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
Uncontrolled Keywords: Nanocarriers,liposomes,mitochondria,mitochondrial dysfunction,targeted drug delivery,Pharmaceutical Science
Publication ISSN: 1029-2330
Last Modified: 31 Mar 2025 07:26
Date Deposited: 09 Dec 2024 14:36
Full Text Link:
Related URLs: https://www.tan ... 6X.2024.2437440 (Publisher URL)
http://www.scop ... tnerID=8YFLogxK (Scopus URL)
PURE Output Type: Review article
Published Date: 2024-12-08
Published Online Date: 2024-12-08
Accepted Date: 2024-11-26
Authors: Sanchez-Aranguren, Lissette (ORCID Profile 0000-0002-4663-5752)
Al Tahan, Mohamad Anas
Uppal, Muhammad
Juvale, Parag
Marwah, Mandeep Kaur (ORCID Profile 0000-0003-4881-003X)

Download

[img]

Version: Published Version

License: Creative Commons Attribution

| Preview

Export / Share Citation


Statistics

Additional statistics for this record